{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:16:46Z","timestamp":1791199006428,"version":"4.1.0"},"reference-count":19,"publisher":"Japanese Pharmacological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2013]]},"DOI":"10.1254\/jphs.13025fp","type":"journal-article","created":{"date-parts":[[2013,7,31]],"date-time":"2013-07-31T23:36:33Z","timestamp":1375313793000},"page":"299-304","source":"Crossref","is-referenced-by-count":37,"title":["Multi-Drug\u2013Resistant Cells Enriched From Chronic Myeloid Leukemia Cells by Doxorubicin Possess Tumor-Initiating\u2013Cell Properties"],"prefix":"10.1254","volume":"122","author":[{"given":"Hong","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ze-Hong","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol. 2010;46:308\u2013316.","DOI":"10.1007\/s12033-010-9321-2"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2006.02.020"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1038\/35102167"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3126"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0530291100"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1038\/nature06489"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730\u2013737.","DOI":"10.1038\/nm0797-730"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.03.027"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kong D, Banerjee S, Ahmad A, Li Y, Wang Z, Sethi S, et al. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One. 2010;5:e12445.","DOI":"10.1371\/journal.pone.0012445"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer. 2005;5:275\u2013284.","DOI":"10.1038\/nrc1590"},{"key":"11","unstructured":"11 Luan FJ. [Establishment of the multidrug-resistant cell line K562\/A02 and its drug-resistant properties]. Zhonghua Zhong Liu Za Zhi. 1993;15:101\u2013103. (text in Chinese with English abstract)"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609062200"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499\u2013507.","DOI":"10.1038\/ng.127"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0626"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.58.062105.204854"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.11.4435"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Calcagno AM, Salcido CD, Gillet JP, Wu CP, Fostel JM, Mumau MD, et al. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics. J Natl Cancer Inst. 2010;102:1637\u20131652.","DOI":"10.1093\/jnci\/djq361"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Dylla SJ, Beviglia L, Park IK, Chartier C, Raval J, Ngan L, et al. Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One; 2008;3:e2428.","DOI":"10.1371\/journal.pone.0002428"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One. 2008;3:e3077.","DOI":"10.1371\/journal.pone.0003077"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/122\/4\/122_13025FP\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T15:10:24Z","timestamp":1621437024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jphs\/122\/4\/122_13025FP\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.13025fp","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}